Home
-
A New Round in US Pharma Tariffs: What’s at Play?
President Trump announced this week a phased plan to impose tariffs on imported generic drugs into the US as a means to encourage US-based production of generics, and a previously announced executive action for tariffs on patented drugs is coming due.
-
In Vivo Cell Therapies: Solving Mfg Obstacles?
Several bio/pharma majors are making a play in in vivo cell therapies with recent $1-billion-plus acquisitions with an aim for both clinical and manufacturing benefits. Are in vivo cell therapies the up-and-coming segment in advanced therapies?
-
J&J Aims To Be $100-Bn Company; Begins Supply-Chain Restructuring
Johnson & Johnson is aiming to cross the $100-billion revenue mark in 2026 and is beginning a multi-year supply-chain restructuring program in its Innovative Medicine segment.
SPONSORED CONTENT
-
SPONSORED CONTENT
Trends Driving the Biopharmaceutical Industry Forward: How CDMOs Maintain Stability in a Complex Global Market
-
SPONSORED CONTENT
A new way of tackling bitterness and elevating drug palatability: ModulaSENSE® Bitter debuts at DCAT Week
-
SPONSORED CONTENT
Engineering Excellence In High Potency Manufacturing: Indena’s Integrated CDMO Platform for HPAPIs and ADCs
DCAT MEMBER COMPANY COMMUNITY
-
DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the world’s largest international pre-college student science and engineering competition that took place in Phoenix, Arizona from May 9–15, 2026. Owned and produced by the Society for Science, Regeneron…
-
ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis
The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving? In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a roundtable of industry experts share their perspectives on the latest in peptide synthesis. Solid-phase peptide synthesis (SPPS) is the dominant method in peptide synthesis, but other approaches, such…
-
New DCAT Member Company Alert
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all DCAT Member Companies, visit the Member Directory at the DCAT website. From the May 8, 2026, issue of DCAT Value Chain Insights: From the May…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the March 6, 2026, issue of DCAT Value Chain Insights: From the January 30, 2026, issue of DCAT Value Chain Insights:
